Correlation between oxidative stress and immunosuppressive therapy in renal transplant recipients with an uneventful postoperative course stable renal function

被引:0
|
作者
Perrea, D [1 ]
Moulakakis, K [1 ]
Papatheodorou, T [1 ]
Tzogios, I [1 ]
Poulakou, M [1 ]
Papachristodoulou, A [1 ]
Kostakis, A [1 ]
机构
[1] Univ Athens, Sch Med, Laiko Hosp, Dept Propedeut Surg 2, GR-11527 Athens, Greece
来源
PROCEEDINGS OF THE XXXIX CONGRESS OF THE EUROPEAN SOCIETY FOR SURGICAL RESEARCH | 2004年
关键词
renal transplantation; oxidative stress; MDA; renal failure;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: Reactive oxygen species (ROS) are important mediators of cellular damage and lipid peroxidation is the most important expression of ROS-induced oxidative stress. Recent studies have suggested that increased plasma malondialdehyde (MDA) levels are a consequence of immunosuppressive therapy. This study aims at investigating the relation between oxidative stress, renal transplantation and the immunosuppressive therapy in patients with an uneventful postoperative course. Patients-Methods: The study group comprised 39 renal patients. Three groups of renal transplant receptors with a different combination of immunosuppressive agents (Cyclosporine A, Tacrolimus, Sirolimus, Mycophenolate mofetil, Daclizumab, Basiliximab and Steroids) were studied. All patients had an uneventful postoperative course. Plasma malondialdehyde (MDA) levels were measured before transplantation and one and six months after. Plasma concentration of endogenous creatinine (Cr) was used as the measure of stable renal function. Results: Levels of MDA were increased before the transplantation in all renal patients. (7.81+/-4.69) Immunosuppressive combined therapy with CsA- Mycophenolate mofetil within I and 6 months was not associated with variability in oxidative stress expression. (Group A MDA: 8.2 vs. 13.1 P=0.15) A statistically significant decrement of MDA levels was observed in Tacrolimus-Mycophenolate mofetil treated patients at 6 months, compared with the preoperative levels.(Group B MDA: 9.2 vs. 4.0, P=0.021) Conclusions: An increased oxidative stress in pretransplant patients suggests an imbalance between toxic oxidants and antioxidants defences. Immunosuppressive combined therapy with CsA was not associated with variability in oxidative stress expression within 1 and 6 months after transplantation. Our study provides strong evidence that Tacrolimus is significantly associated with improved free radical metabolism.
引用
收藏
页码:165 / 171
页数:7
相关论文
共 33 条
  • [21] Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients
    Reinders, Marlies E. J.
    Bank, Jonna R.
    Dreyer, Geertje J.
    Roelofs, Helene
    Heidt, Sebastian
    Roelen, Dave L.
    Huurman, Volkert A. L.
    Lindeman, Jan
    van Kooten, Cees
    Claas, Frans H. J.
    Fibbe, Wim E.
    Rabelink, Ton J.
    de Fijter, Johan W.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [22] Tacrolimus-Based Immunosuppressive Therapy Influences Sex Hormone Profile in Renal-Transplant Recipients-A Research Study
    Szypulska-Koziarska, Dagmara
    Wilk, Aleksandra
    Marchelek-Mysliwiec, Malgorzata
    Sleboda-Taront, Daria
    Wiszniewska, Barbara
    BIOLOGY-BASEL, 2021, 10 (08):
  • [23] Mineralocorticoid Receptor Blockade Reduced Oxidative Stress in Renal Transplant Recipients: A Double-Blind, Randomized Pilot Study
    Ojeda-Cervantes, Marcos
    Barrera-Chimal, Jonatan
    Alberu, Josefina
    Perez-Villalva, Rosalba
    Eduardo Morales-Buenrostro, Luis
    Bobadilla, Norma A.
    AMERICAN JOURNAL OF NEPHROLOGY, 2013, 37 (05) : 481 - 490
  • [24] Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy
    Granata, Simona
    Santoro, Gloria
    Signorini, Lorenzo
    Malerba, Giovanni
    Patuzzo, Cristina
    Gambaro, Giovanni
    Stallone, Giovanni
    Zaza, Gianluigi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 859
  • [25] Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease
    Pawlak, Krystyna
    Pawlak, Dariusz
    Mysliwiec, Michal
    CLINICAL BIOCHEMISTRY, 2007, 40 (1-2) : 81 - 85
  • [26] Cytomegalovirus infection alters phenotypes of different γδ T-cell subsets in renal transplant recipients with long-term stable graft function
    Lee, Silvia
    Affandi, Jacquita S.
    Irish, Ashley B.
    Price, Patricia
    JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (08) : 1442 - 1452
  • [27] Correlation between serum YKL-40 (Chitinase-3-like protein 1) level and proteinuria in renal transplant recipients
    Tatar, Erhan
    Gungor, Ozkan
    Celtik, Aygul
    Sisman, Ali Riza
    Yaprak, Mustafa
    Asci, Gulay
    Ozkahya, Mehmet
    Toz, Huseyin
    ANNALS OF TRANSPLANTATION, 2013, 18 : 95 - 100
  • [28] Association between endothelial and platelet function markers and adiponectin in renal transplanted recipients on cyclosporine and tacrolimus immunosuppression based therapy
    Sahin, Garip
    Akay, Olga Meltem
    Uslu, Sema
    Bal, Cengiz
    Yalcin, Ahmet Ugur
    Gulbas, Zafer
    NEPHROLOGY, 2015, 20 (06) : 392 - 398
  • [29] Open comparison study of oxidative stress markers between patients with chronic renal failure in conservative therapy and patients in haemodialysis
    Coaccioli, S.
    Standoli, M. L.
    Biondi, R.
    Panaccione, A.
    Landucci, P.
    Del Giorno, R.
    Paladini, A.
    Standoli, M.
    Puxeddu, A.
    CLINICA TERAPEUTICA, 2010, 161 (05): : 435 - 439
  • [30] Association of high IFN-γ plasma levels with low B-cell counts in renal transplant recipients with stable long-term graft function
    Daniel, Volker
    Naujokat, Cord
    Sadeghi, Mahmoud
    Renner, Fabrice Christoph
    Weimer, Rolf
    Opelz, Gerhard
    CLINICAL TRANSPLANTATION, 2010, 24 (02) : 281 - 289